Prev : Next Sanderling Ventures
Focused exclusively on biomedicine
Molecular biologist Robert McNeil founds Sanderling Ventures. The firm specializes in seeding start-up biomedical companies and is one of California’s oldest venture capital firms. From its inception, Sanderling steers its portfolio firms through volatile conditions in the biotech industry with an investment and management approach that McNeil describes as “company-building mode.” A cardinal principle is that start-up success is keyed by long-term relationships with robust management and R&D teams. When other venture capital outfits periodically abandon the biotech sector for computing, software, and infotech opportunities, Sanderling remains and continues to deliver necessary financial resources to early-stage life science companies. In its thirty-two year history, the firm guides more than ninety biotech and biomedical device companies through market climates good and bad.